Who Paid My Doc
Tarlatamab 20200439
Research payments
$1,470,571
Through program year 2024, $1,470,571 in research payments was reported against Tarlatamab 20200439, across 38 payments, paid by Amgen Inc..
- Paid by
- Amgen Inc.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
4 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2024 | Research | $821,489 | 5 |
| 2023 | Research | $377,853 | 13 |
| 2022 | Research | $112,835 | 12 |
| 2021 | Research | $158,394 | 8 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
7 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Melissa Johnson Nashville, TN Named on 7 payments
- Jyoti Patel Chicago, IL Named on 4 payments
- Afshin Dowlati Cleveland, OH Named on 4 payments
- Mariam Alexander Charleston, SC Named on 3 payments
- Zhonglin Hao Lexington, KY Named on 3 payments
- William Petty Winston Salem, NC Named on 2 payments
- Wallace Akerley Salt Lake City, UT Named on 2 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.